LJPC
La Jolla Pharmaceutical Company
LJPC
LJPC
Delisted
LJPC was delisted on the 19th of August, 2022.
95 hedge funds and large institutions have $828M invested in La Jolla Pharmaceutical Company in 2017 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 29 increasing their positions, 26 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
88% less call options, than puts
Call options by funds: $5.35M | Put options by funds: $44M
Holders
95
Holding in Top 10
5
Calls
$5.35M
Puts
$44M
Top Buyers
| 1 | +$14.6M | |
| 2 | +$13.3M | |
| 3 | +$10.4M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.77M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$6.29M |
Top Sellers
| 1 | -$25.2M | |
| 2 | -$15.1M | |
| 3 | -$12.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$8.91M |
| 5 |
BC
Broadfin Capital
New York
|
-$6.95M |